iShares Russell 2000 ETF (IWM)

Rocket Pharmaceuticals said that it is working with the FDA to ensure safety of all study patients and resume the trial “as expeditiously as possible."

The extended weekend also delivered the company’s strongest Memorial Day performance to date in both ticket sales and concessions revenue on the domestic front.

President Donald Trump confirmed over the weekend that he has extended the implementation of 50% tariffs on the European Union until July 9 to allow time for negotiations.

The company expects the deal to close in the second half of 2025, and the stock will cease to trade on the NYSE following the closing.

The data show a market that is weakening internally, with fewer stocks supporting any upside and an increasing tilt toward broad-based selling.

Wall Street stumbled midday Friday, shaken by a fresh wave of trade war fears after President Donald Trump proposed aggressive new tariffs on Apple Inc. (NASDAQ:AAPL)

The economic calendar for the day is fairly light, with speeches by a few Federal Reserve officials and the Commerce Department’s new home sales report for April on tap.

The market is in a cautious phase with waning momentum.

Wall Street edges higher as GOP tax bill clears the House and bond yields ease, helping investors shake off prior losses while digesting mixed May business activity data.

Analysts raised price targets, citing strong guidance and resilient performance despite macroeconomic challenges.

The broad-based selling on May 21 wasn't a surprise, it was preceded by several days of narrowing breadth.

A strategist said that, against the backdrop of trade policy uncertainty, it is prudent to keep tactical asset allocations closer to benchmarks than when there is more economic clarity.

The Food and Drug Administration is expected to conclude its review of UroGen’s UGN-102 application by June 13.

U.S. equities trading was mixed on Wednesday, with major indices showing limited movement by midday as investors remained cautious amid renewed concerns over fiscal policy, which pressured Treasury bonds and the dollar.

After a sharp 23% rebound in the S&P 500 since April, hedge funds are now stacking record levels of bearish bets against stocks as investors question the staying power of the tariff-relief rally.

While the major indices are holding up, breadth is beginning to diverge and fewer stocks are driving the rally, market participation is waning.

On Tuesday, nine of the 11 sector classes closed in the red, with the defensive consumer staple, utility and healthcare stocks bucking the downtrend.

U.S. stocks pulled back Tuesday morning as Wall Street recalibrated expectations on growth and inflation amid rising fiscal risks tied to President Donald Trump's sweeping tax proposal.

The expanded partnership provides refined access to premium ad demand and broadens Fire TV inventory reach.

Markets continued to show resilience at the start of the week, with all major indices maintaining their short-term bullish trends.

The brokerage believes the S&P 500's upside through the 6,100 mark depends on continued reacceleration in earnings revisions, as interest rate relief remains elusive.

U.S. stocks trimmed early-session losses by midday Monday, as investors showed limited concern after Moody's downgraded U.S. sovereign credit from Aaa to Aa1, effectively stripping the world's largest economy of its last top-tier credit rating.

The short-term trend remains bullish across all major indices, supported by strong market breadth and price action.

New York Fed President John Williams and Fed Chair Philip Jefferson are due to speak before the market opens on Monday.

The return to a more stable trade environment may create a short-term tailwind for small stocks, particularly those that derive the bulk of their revenues within the U.S.